Skip to Content

Apokyn Approval History

FDA Approved: Yes (First approved April 20, 2004)
Brand name: Apokyn
Generic name: apomorphine
Dosage form: Injection
Company: Bertek Pharmaceuticals
Treatment for: Parkinson's Disease

Apokyn (apomorphine) is a non-ergoline dopamine agonist indicated for the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose wearing off" and unpredictable "on/off" episodes) associated with advanced Parkinson’s disease.

Development History and FDA Approval Process for Apokyn

DateArticle
Apr 20, 2004Approval Apokyn Bertek Pharmaceuticals - Treatment for Parkinson’s Disease

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide